Yiheng Capital Management’s Akero Therapeutics AKRO Stock Holding History

Yiheng Capital Management’s Portfolio AKRO Stock Details AKRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-751,500	Closed	-$30.4M	–	26
2025 Q1	$30.4M	Buy	+751,500	New	+$31.9M	2.83%	6
2023 Q2	–	Sell	-163,800	Closed	-$6.27M	–	32
2023 Q1	$6.27M	Sell	163,800 -162,700	-50%	-$7.25M	0.25%	26
2022 Q4	$17.9M	Buy	326,500 +250,700	+331%	+$10.7M	0.79%	20
2022 Q3	$2.58M	Buy	+75,800	New	+$1.16M	0.16%	29

Other funds holding AKRO

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Yiheng Capital Management's AKRO Position: Q4 2025 in Review

Yiheng Capital Management sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 191,076 shares — an estimated $9.07M sold.

Yiheng Capital Management first reported a position in AKRO in Q1 2021 and held it in 19 quarters. The position peaked at $80.5M in Q4 2022. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

Yiheng Capital Management reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
Yiheng Capital Management sold 191,076 Akero Therapeutics shares in Q4 2025, an estimated $9.07M.
Yiheng Capital Management first reported a position in Akero Therapeutics in Q1 2021 and held it in 19 quarters.
Yiheng Capital Management's Akero Therapeutics position peaked at $80.5M in Q4 2022.
2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Yiheng Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.